Xencor is a biotechnology company based in Pasadena, California, specializing in the discovery and development of engineered monoclonal antibodies for the treatment of various diseases. Located in the 91107 area, Xencor combines advanced scientific research with innovative technologies to create novel therapeutic candidates aimed at addressing unmet medical needs. The company’s work involves a deep understanding of protein engineering and immunology to enhance the effectiveness and safety profiles of biologic drugs.
Situated at 465 N Halstead St Ste. 200, Xencor operates within a dynamic biotech hub, fostering collaborations with academic institutions, pharmaceutical partners, and research organizations. The team at Xencor engages in rigorous laboratory and clinical development activities, focusing on translating scientific discoveries into practical treatments. Their efforts contribute to the broader field of biotechnology by advancing therapies that may improve patient outcomes across multiple therapeutic areas.
Xencor supports both on-site and remote engagements, offering accessibility to partners and clients in Pasadena and the surrounding regions. The company’s commitment to innovation is reflected in its approach to research and development, where cutting-edge methods are employed to optimize drug candidates. Through a combination of scientific expertise and strategic development, Xencor plays a significant role in the local and national biotechnology landscape.
Serving the community and industry professionals in Pasadena, Xencor is a key player in California’s biotechnology sector. Its location and resources provide a foundation for ongoing growth and contribution to medical science. Those interested in learning more about Xencor’s capabilities and projects can reach the company directly via telephone at 626-305-5900.


































